$VRX upturn. now FDA $16.86
reverse head and
$VRX upturn. now FDA $16.86
reverse head and shoulders
candles at breakout
Website
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab)
For Moderate-To-Severe Plaque Psoriasis CNW Group -
1 hour ago ago
Last ten trades
Stock Analylsis
Shares Outstanding 341.19M
Float 304.95M
% Held by Insiders 1.96%
% Held by Institutions 88.00%
Shares Short 35.6M
Short Ratio 2.39
Short % of Float 13.83%
Shares Short (prior month) 30.42M
News
and filings
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September, 2010. The company was founded in 1983 and is based in Laval, Canada
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...
Continue Reading
Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...
Continue Reading
Elah Holdings Drops Their Q3 2026 Numbers Eat your heart out, folks—Elah Holdings has just dropped their third quarter report for 2026, and it caught some eyes. This ain't your run-of-the-mill, brush-right-past-it release. They're out there, waving their flag high in the competitive marketplace, trying to tell us they mean business. If you missed the announcement, they...
Continue Reading
Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...
Continue Reading
What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...
Continue Reading
Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...
Continue Reading
Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...
Continue Reading
Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...
Continue Reading
Insurance paperwork rarely looks heroic, yet it can decide whether treatment starts before a crisis gets worse. Recovery Centers of America at Mount Dora has added Aetna and Cigna/Evernorth to its in-network roster for every level of substance use disorder care, a practical move with real consequences for patients and families across Central Florida. Coverage matters most...
Continue Reading
A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Developments at Cotino Bay Beach A vibrant new community is set to emerge with the opening of Cotino Bay Beach, Dining and Shops in fall 2026. The first Storyliving by Disney community is gearing up to offer an array of dining and retail experiences, creating a unique destination for residents and visitors alike. Restaurants to Enrich the Community Among the...
Continue Reading
Introduction to the Share Repurchase Program dsm-firmenich, a leader in nutrition, health, and beauty, has embarked on a significant share repurchase program with the aim of enhancing shareholder value and strategically managing its capital. By initiating this buyback, dsm-firmenich demonstrates its commitment to returning value to its investors while still investing in...
Continue Reading
Investigation of Arvinas, Inc. Pomerantz LLP is looking into potential claims on behalf of investors of Arvinas, Inc. (NASDAQ: ARVN). This investigation aims to uncover whether the company and its executives may have engaged in securities fraud or other illegal business practices. Recent Developments Arvinas has recently communicated significant changes to its clinical...
Continue Reading
Gantry got its hands on Triad Capital Advisors back in 2023, and it was no small move. This merger wasn't just about beefing up their operational muscle; it expanded Gantry's footprint in the Midwest finance scene big time. It’s like they dropped a bomb on their competitors without warning—traders watching closely could feel the shift coming. With this acquisition,...
Continue Reading
The Emergence of Port Athena in Tartu Move over, sleepy towns—Tartu's staking its claim with the Port Athena development. What we're looking at is more than just another block of buildings. It's practically a new district, nestled on the banks of the Emajõgi River. Forget the stereotypical old-world charm; we're talking sleek, modern architecture that's ready to become...
Continue Reading